Aspira Pathlab & Diagnostics Ltd.

As of June 30, 2026, Aspira Pathlab & Diagnostics Ltd. carries a market capitalization of 1.34B, placing it among publicly traded companies globally. Its enterprise value stands at 1.34B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Aspira Pathlab & Diagnostics Ltd. has 10.29M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Aspira Pathlab & Diagnostics Ltd. trades at an EV/EBITDA multiple of 135.23 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 5.17 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.34B versus a market cap of 1.34B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 1.68M in revenue per employee across its workforce of 154.50, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Aspira Pathlab & Diagnostics Ltd.'s stock has gained approximately 94.07% over the past 52 weeks. The 50-day moving average sits at 108.13, while the 200-day moving average is 89.12.

Over the twelve months ended June 30, 2026, Aspira Pathlab & Diagnostics Ltd. generated 259.03M in revenue and converted that into -4.53M in net income, yielding earnings per share of -0.45. EBITDA reached 9.90M, while operating income came in at -5.93M.

Over the twelve months ended June 30, 2026, Aspira Pathlab & Diagnostics Ltd. posted a gross margin of 77.12, reflecting its pricing power and cost economics. The operating margin of -2.29 and net profit margin of -1.75 provide insight into operational efficiency.